Walleye Capital’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,301
Closed -$18.7K 5030
2025
Q1
$18.7K Sell
15,301
-14,837
-49% -$36.5K ﹤0.01% 4009
2024
Q4
$91K Buy
+30,138
New +$84.7K ﹤0.01% 4175
2023
Q1
Sell
-24,554
Closed -$282K 4358
2022
Q4
$282K Sell
24,554
-5,286
-18% -$47.4K 0.01% 1832
2022
Q3
$254K Buy
+29,840
New +$247K ﹤0.01% 1954
2021
Q3
Sell
-11,747
Closed -$189 1808
2021
Q2
$189 Buy
+11,747
New +$161K 0.01% 1073

Other funds holding TELA

Walleye Capital's TELA Position: Q2 2025 in Review

Walleye Capital sold out of TELA Bio (TELA) in Q2 2025, closing a stake of 15,301 shares — an estimated $18.7K sold.

Walleye Capital first reported a position in TELA in Q2 2021 and held it in 5 quarters. The position peaked at $282K in Q4 2022. 46 funds tracked by Wall St. Rank hold TELA as of Q2 2025.

  • Walleye Capital reported no remaining TELA Bio position as of Q2 2025 after selling out during the quarter.
  • Walleye Capital sold 15,301 TELA Bio shares in Q2 2025, an estimated $18.7K.
  • Walleye Capital first reported a position in TELA Bio in Q2 2021 and held it in 5 quarters.
  • Walleye Capital's TELA Bio position peaked at $282K in Q4 2022.
  • 46 funds tracked by Wall St. Rank held TELA Bio as of Q2 2025.

Based on Walleye Capital's 13F filing for Q2 2025, filed 13 Aug 2025.